Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats.
D000236:Adenoma / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D004032:Diet; D004052:Diethylnitrosamine; D004347:Drug Interactions; D005260:Female; D006651:Histocytochemistry; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000378:metabolism; D011230:Precancerous Conditions / Q000139:chemically induced; D051381:Rats; D005723:gamma-Glutamyltransferase / Q000032:analysis
D003276:Contraceptives, Oral; D003280:Contraceptives, Oral, Synthetic; D004052:Diethylnitrosamine; D005723:gamma-Glutamyltransferase